I think the price target is a little stretched, BUT-- many a...
I think the price target is a little stretched, BUT-- many are predicting that Humira going off patent will destroy
$AbbVie (ABBV.US)$. I think the newer drugs getting approval daily will nullify the ABBV is "doomed" naysayers. ABBV going higher....
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more1 35
Brandon Golden : Long and Proud...
Geminiasianboi Brandon Golden : ♫ I'm a long, proud Texan ♪
IT farmer : Easy and cheap stock just like BMY. They should also upgrade AT&T to $35, $25 is just ridiculous :D
Marvan IT farmer : T is worthless they removed the dividend
r8ntdxstAw Marvan : What do you mean, "they removed the dividend"?
It's going to be reduced, but not eliminated.
xoshi8HiuI Marvan : Get your facts right. The div will be cut by like 50% in exchange for shares in the spin-off/merger. Even with a 50% cut it would be above 4% right now. I won't sell any shares in T and keep them as long as necessary. But yeah ABBV is surely a great company and stock with actual dividend growth that is staggering :)
EshoROsvP7 xoshi8HiuI : ABBV is awesome for dividend and capital appreciation growth.
T not so much.
LIKE 60% thats a lott
t1i5xTWxyB Marvan : Classic FAKE NEWS
moonoooooo IT farmer : they are rotating from growth to value the past week but T may get cheaper